ஸ்பெக்ட்ரம் மருந்துகள் நாஸ்டாக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்பெக்ட்ரம் மருந்துகள் நாஸ்டாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்பெக்ட்ரம் மருந்துகள் நாஸ்டாக் Today - Breaking & Trending Today

Spectrum Pharmaceuticals, Inc.: Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021


Spectrum Pharmaceuticals, Inc.: Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced two presentations, one oral and one eposter, at the upcoming European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) Virtual Congress 2021. The oral presentation will provide some initial safety and efficacy data for poziotinib from the twice daily dosing cohort. The meeting takes place on March 1 2, 2021. Details of the presentations are as follows:
Title: IGN002 (antiCD20-IFNa2b) intravenously administered tumor targeted delivery of IFNa2b and its effects in non-Hodgkin lymphoma ....

Kurt Gustafson , Robert Uhl , Adrian Sacher , Sribalaji Lakshmikanthan , Spectrum Pharmaceuticals Nasdaq , Exchange Commission , Spectrum Pharmaceuticals Inc , Aboutspectrum Pharmaceuticals Inc , Spectrum Pharmaceuticals , Virtual Congress , European Society , Medical Oncology Targeted Anticancer Therapies , Mini Oral Session , All Rights , Financial Officer , கர்ட் குஸ்டாஃப்சன் , ராபர்ட் அல் , ஸ்பெக்ட்ரம் மருந்துகள் நாஸ்டாக் , பரிமாற்றம் தரகு , ஸ்பெக்ட்ரம் மருந்துகள் இன்க் , ஸ்பெக்ட்ரம் மருந்துகள் , மெய்நிகர் காங்கிரஸ் , ஐரோப்பிய சமூகம் , மினி வாய்வழி அமர்வு , அனைத்தும் உரிமைகள் , நிதி அதிகாரி ,

Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors


Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Nora Brennan to its Board of Directors. Ms. Brennan fills a vacancy left by Ms. Elizabeth Czerepak, who retired from the Board effective December 10, 2020.
We are delighted to have Ms. Brennan join Spectrums Board of Directors as the company continues to focus its development efforts on novel treatments for patients with cancer, said William Ashton, Chairman of the Board, Spectrum Pharmaceuticals. Her leadership and experience in the pharmaceutical and medical technology sectors make her an ideal contributor to our future growth. We would also like to thank Ms. Czerepak for her dedicated service and numerous contributions to the Board, and we wish her well in all of her future e ....

Kurt Gustafson , Elizabeth Czerepak , Robert Uhl , William Ashton , Nora Brennan , Xeris Pharmaceuticals Inc , University Of Chicago Booth School Business , Spectrum Pharmaceuticals , Bio Inc , Spectrum Pharmaceuticals Nasdaq , Exchange Commission , Master Of Business Administration , University Of Illinois , Jp Morgan , Spectrum Pharmaceuticals Inc , Integra Lifesciences Corporation , Spectrums Board , Chief Financial Officer , Xeris Pharmaceuticals , Senior Vice President , Investor Relations , Business Administration , Chicago Booth School , All Rights , கர்ட் குஸ்டாஃப்சன் , ராபர்ட் அல் ,